← Back
Data updated: Mar 29, 2026
CHARTWELL MOLECULAR
CardiovascularInfectious DiseaseGastroenterology
Generics
CHARTWELL MOLECULAR is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Gastroenterology.
1963
Since
79
Drugs
-
Trials
1278
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
BOSENTAN 2026-02-17
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
OLANZAPINE 2026-02-09
Labeling
OLANZAPINE 2026-02-09
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
LAMOTRIGINE 2026-01-30
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 31%
5 drugs
Infectious Disease 19%
3 drugs
Gastroenterology 19%
3 drugs
Neurology 19%
3 drugs
Dermatology 13%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Dermatology
PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Neurology, Cardiovascular
Active (31)
IRBESARTAN LAMIVUDINE LEVOCETIRIZINE DIHYDROCHLORIDE ANASTROZOLE LANSOPRAZOLE ASPIRIN AND DIPYRIDAMOLE LEVETIRACETAM DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE ZALEPLON CETIRIZINE HYDROCHLORIDE CALCIUM ACETATE GRANISETRON HYDROCHLORIDE CARVEDILOL TRANDOLAPRIL ONDANSETRON HYDROCHLORIDE SERTRALINE HYDROCHLORIDE LAMOTRIGINE RAMIPRIL RIFAMPIN ACYCLOVIR CLINDAMYCIN HYDROCHLORIDE ALBUTEROL SULFATE AMANTADINE HYDROCHLORIDE BETAMETHASONE DIPROPIONATE METHYLPHENIDATE HYDROCHLORIDE ACETAZOLAMIDE DOXYCYCLINE HYCLATE HYDROCHLOROTHIAZIDE DEXAMETHASONE NEOMYCIN SULFATE PROPYLTHIOURACIL
Discontinued (47)
BOSENTAN SULFAMETHOXAZOLE AND TRIMETHOPRIM OLANZAPINE FLUOXETINE HYDROCHLORIDE OXALIPLATIN OXYCODONE HYDROCHLORIDE LORAZEPAM MORPHINE SULFATE POTASSIUM CHLORIDE ACETAMINOPHEN AND CODEINE PHOSPHATE MOMETASONE FUROATE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF SUMATRIPTAN SUCCINATE RISPERIDONE ESCITALOPRAM OXALATE PREDNISONE MONTELUKAST SODIUM MEMANTINE HYDROCHLORIDE QUINIDINE SULFATE FOLIC ACID METOCLOPRAMIDE HYDROCHLORIDE ISOSORBIDE MONONITRATE PROMETHAZINE HYDROCHLORIDE PREDNISOLONE THEOPHYLLINE GLIMEPIRIDE HYDROCORTISONE METHOCARBAMOL CLOBAZAM LANIAZID ZOLPIDEM TARTRATE CITALOPRAM HYDROBROMIDE SULFADIAZINE LEVOFLOXACIN CIMETIDINE HYDROCHLORIDE CORTISONE ACETATE LIDOCAINE HYDROCHLORIDE VISCOUS AMINOPHYLLINE BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE CYPROHEPTADINE HYDROCHLORIDE FURALAN MEPROBAMATE VITAMIN D MYKROX QUINALAN DIPHENYLAN SODIUM
Company Info
- First Approval
- 1963-08-09
- Latest
- 2025-12-22
- Applications
- 91